HERDSMEN KILL DRIVER ON HUMANITARIAN MISSION IN TARABA STATE. (PHOTO).

Image
 HERDSMEN KILL DRIVER ON HUMANITARIAN MISSION IN TARABA STATE  10th January, 2026      A commercial driver, Mr. Amishe Omeny, has been killed by suspected Fulani herdsmen while on a humanitarian visit to a displaced community in Takum Local Government Area of Taraba State. The deceased, from Tse Amise after Tseem, was reportedly attacked on Friday within Chanchanji Ward as he travelled to Adokia, a displaced settlement located after Tseem Sabe. He was said to have gone to the area to assist villagers with the transportation of foodstuffs. Sources in the community told Benue Info-pedia, that Omeny volunteered his services as a driver to support residents affected by ongoing insecurity, when he was ambushed and killed by the assailants. The killing has sparked grief and outrage among residents, who described the incident as tragic and senseless. They called on security agencies and the Taraba State Government to urgently step up protection for displaced communitie...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

TINUBU ANNOUNCES ARRIVAL OF 4 U.S ATTACK HELICOPTERS. (PHOTO).